Diane Ramsden

2.8k total citations · 1 hit paper
86 papers, 2.1k citations indexed

About

Diane Ramsden is a scholar working on Radiation, Oncology and Pharmacology. According to data from OpenAlex, Diane Ramsden has authored 86 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Radiation, 22 papers in Oncology and 20 papers in Pharmacology. Recurrent topics in Diane Ramsden's work include Radiation Detection and Scintillator Technologies (22 papers), Pharmacogenetics and Drug Metabolism (20 papers) and Drug Transport and Resistance Mechanisms (20 papers). Diane Ramsden is often cited by papers focused on Radiation Detection and Scintillator Technologies (22 papers), Pharmacogenetics and Drug Metabolism (20 papers) and Drug Transport and Resistance Mechanisms (20 papers). Diane Ramsden collaborates with scholars based in United Kingdom, United States and Japan. Diane Ramsden's co-authors include G. J. Boer, Gregory M. Flato, M. C. Reader, Andrew J. Weaver, N. A. McFarlane, Warren G. Lee, Ling-Jian Meng, Donald Tweedie, R Hoffenberg and Stuart Evans and has published in prestigious journals such as Gastroenterology, Antimicrobial Agents and Chemotherapy and International Journal of Pharmaceutics.

In The Last Decade

Diane Ramsden

78 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Canadian Centre for Climate Modelling and Analysis global coupled model and its climate

2000 523 citations Diane Ramsden et al. profile →

Peers

Countries citing papers authored by Diane Ramsden

Since Specialization

Citations

This map shows the geographic impact of Diane Ramsden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane Ramsden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane Ramsden more than expected).

Fields of papers citing papers by Diane Ramsden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane Ramsden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane Ramsden. The network helps show where Diane Ramsden may publish in the future.

Co-authorship network of co-authors of Diane Ramsden

This figure shows the co-authorship network connecting the top 25 collaborators of Diane Ramsden. A scholar is included among the top collaborators of Diane Ramsden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane Ramsden. Diane Ramsden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advancing Predictions of Oral Drug Absorption, CYP3A4 Induction, and Transporter‐Mediated Interactions Using a Human Primary Intestinal 3D Model ( EpiIntestinal™ ) 2025 ·Clinical Pharmacology & Therapeutics ·Paresh P. Chothe, (unknown), (unknown), Diane Ramsden, Niresh Hariparsad	0
2	Assessing complex drug-drug interactions using the truvivotm hepatocyte model 2024 ·Drug Metabolism and Pharmacokinetics ·(unknown), (unknown), Douglas Ferguson, Niresh Hariparsad, Diane Ramsden	1
3	Aminobenzotriazole inhibits and induces several key drug metabolizing enzymes complicating its utility as a pan CYP inhibitor for reaction phenotyping 2024 ·Clinical and Translational Science ·Krishna Aluri, (unknown), Ying Tan, (unknown), Zhoupeng Zhang, Niresh Hariparsad, Diane Ramsden	3
4	Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression 2024 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Theresa A. Proia, (unknown), (unknown), Matthew Sung, Srinivas Mamidi, (unknown), Matthew Griffin, (unknown), Jelena Urosevic, Anton I. Rosenbaum, Jiaqi Yuan, Krishna Aluri, Diane Ramsden, Niresh Hariparsad, Rhys D.O. Jones, Jerome T. Mettetal	7
5	Tiered approach to evaluate the CYP3A victim and perpetrator drug–drug interaction potential for vonoprazan using PBPK modeling and clinical data to inform labeling 2023 ·CPT Pharmacometrics & Systems Pharmacology ·Darcy J. Mulford, Diane Ramsden, Liming Zhang, Ingrid Michon, Eckhard Leifke, Neila Smith, Hannah M. Jones, Carmelo Scarpignato	8
6	Innovations, Opportunities, and Challenges for Predicting Alteration in Drug-Metabolizing Enzyme and Transporter Activity in Specific Populations 2023 ·Drug Metabolism and Disposition ·Paresh P. Chothe, Vikram Arya, Bhagwat Prasad, Diane Ramsden, Kunal S. Taskar	3
7	Pharmacokinetic evaluation of poorly soluble compounds formulated as nano- or microcrystals after intraperitoneal injection to mice 2023 ·International Journal of Pharmaceutics ·Krishna Aluri, Kalle Sigfridsson, (unknown), Niresh Hariparsad, Dermot F. McGinnity, Diane Ramsden	3
8	Characterization of Correction Factors to Enable Assessment of Clinical Risk from In Vitro CYP3A4 Induction Data and Basic Drug-Drug Interaction Models 2022 ·European Journal of Drug Metabolism and Pharmacokinetics ·Diane Ramsden, (unknown)	11
9	Predictive In Vitro-In Vivo Extrapolation for Time Dependent Inhibition of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and CYP2D6 Using Pooled Human Hepatocytes, Human Liver Microsomes, and a Simple Mechanistic Static Model 2021 ·Drug Metabolism and Disposition ·Diane Ramsden, Elke S. Perloff, (unknown), (unknown), Reena Patel, Kirk Kozminski, (unknown), George Zhang	12
10	Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro Cytochrome P450 Induction Studies Including Impact on Drug Interaction Risk Assessment 2020 ·Drug Metabolism and Disposition ·Simon Wong, Diane Ramsden, Shannon Dallas, (unknown), Heidi J. Einolf, Jairam Palamanda, Liangfu Chen, Theunis C. Goosen, (unknown), George Zhang, Donald Tweedie, Niresh Hariparsad, Barry Jones, Phillip D. Yates	17
11	Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control 2017 ·Drug Metabolism and Disposition ·Niresh Hariparsad, Diane Ramsden, Jairam Palamanda, (unknown), Odette A. Fahmi, Jane R. Kenny, Heidi J. Einolf, Michael A. Mohutsky, (unknown), (unknown), Liangfu Chen, Michael Sinz, Barry Jones, Robert L. Walsky, Shannon Dallas, Suresh K. Balani, George Zhang, David B. Buckley, Donald Tweedie	33
12	Evaluation of CYP2B6 Induction and Prediction of Clinical Drug–Drug Interactions: Considerations from the IQ Consortium Induction Working Group—An Industry Perspective 2016 ·Drug Metabolism and Disposition ·Odette A. Fahmi, Mohamad Shebley, Jairam Palamanda, Michael Sinz, Diane Ramsden, Heidi J. Einolf, (unknown), Hongwu Wang	38
13	Determination of a Degradation Constant for CYP3A4 by Direct Suppression of mRNA in a Novel Human Hepatocyte Model, HepatoPac 2015 ·Drug Metabolism and Disposition ·Diane Ramsden, Jin Zhou, Donald Tweedie	39
14	Generating an In Vitro–In Vivo Correlation for Metabolism and Liver Enrichment of a Hepatitis C Virus Drug, Faldaprevir, Using a Rat Hepatocyte Model (HepatoPac) 2013 ·Drug Metabolism and Disposition ·Diane Ramsden, Donald Tweedie, (unknown), Linzhi Chen, Yongmei Li	20
15	Bridging In Vitro and In Vivo Metabolism and Transport of Faldaprevir in Human Using a Novel Cocultured Human Hepatocyte System, HepatoPac 2013 ·Drug Metabolism and Disposition ·Diane Ramsden, Donald Tweedie, Tom S. Chan, Mitchell E. Taub, Yongmei Li	56
16	The effect of counting statistics on the integrity of deconvolved gamma-ray spectra 2003 ·2003 IEEE Nuclear Science Symposium. Conference Record (IEEE Cat. No.03CH37515) ·(unknown), (unknown), Diane Ramsden	1
17	The detection of minimum ionizing particles with multi-pixel hybrid photodiodes 2002 ·1997 IEEE Nuclear Science Symposium Conference Record ·(unknown), Ling-Jian Meng, Diane Ramsden	0
18	Regulation of α and thyrotrophin-β subunit mRNA levels by androgens in the female rat 1990 ·Journal of Molecular Endocrinology ·James Ahlquist, J. A. Franklyn, Diane Ramsden, Michael C. Sheppard	9
19	Ioxynil and 3,5,3′-triiodothyronine: comparison of binding to human plasma proteins 1988 ·Toxicology Letters ·(unknown), Diane Ramsden	9
20	Direct comparisons of human and animal data for plutonium oxide inhalation. 1979 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Diane Ramsden	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact